FindTrial
Sign In

Role of flow cytometric immunophenotyping in staging of pediatric solid round cell tumors

"Investigating the role of flow cytometric immunophenotyping in staging of pediatric solid round cell tumors"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/02/007944
Enrollment
60
Registered
2017-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Newly diagnosed patients with RCT including neuroblastoma rhabdomayosarcoma, EWS/PNET and retinoblastoma Age less or equal to 15 years

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with RCT including neuroblastoma, rhabdomayosarcoma, EWS/PNET, and retinoblastoma. Age less or equal to 15 years.

Exclusion criteria

Exclusion criteria: Patient who is not taking treatment in TMC

Design outcomes

Primary

MeasureTime frame
Percentage involvement in bone marrow and peripheral blood by RCTTimepoint: Peripheral blood samples will be collected at the tile of routine bone marrow biopsy—

Secondary

MeasureTime frame
To evaluate the efficacy of FC immunophenotyping in the detection of metastasis of RCT in the bone marrow.Timepoint: The patients in this study will not have any immediate benefit. With this project, we investigate a sensitive and faster technique for detection and percentage of bone marrow involvement and also circulating tumor cells—

Countries

India

Contacts

Public ContactDr Kavita Khirwal

Tata Memorial Hospital

docprt@gmail.com9987814038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026